Finance

Lists
Why is HEMO up 14,84%?
Dive Deeper
HEMO:LON
Hemogenyx Pharmaceuticals PLC
GBX 735,00
+14,84%
(+95,00) 1D
9 Okt., 16:35:05 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for HEMO...
Open
GBX 633,00
High
GBX 735,00
Low
GBX 600,00
Mkt. cap
50,69 m
Avg. vol.
28,41 k
Volume
27,99 k
52-wk high
GBX 1 270,00
52-wk low
GBX 356,00
EPS
-GBX 1,91
Shares outstanding
6,90 m
No. of employees
16
Open
GBX 633,00
High
GBX 735,00
Low
GBX 600,00
Mkt. cap
50,69 m
Avg. vol.
28,41 k
Volume
27,99 k
52-wk high
GBX 1 270,00
52-wk low
GBX 356,00
EPS
-GBX 1,91
Shares outstanding
6,90 m
No. of employees
16
News stories
From web sources and news partners
About Hemogenyx Pharmaceuticals PLC
CEO-
Employees16
Founded2013
Headquarters-
Sector-
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,06 m
2,06 m
848,18 k
848,18 k
Operating expense
2,16 m
2,16 m
3,69 m
3,69 m
Total operating expenses
2,16 m
2,16 m
3,69 m
3,69 m
Operating income
-2,16 m
-2,16 m
-3,69 m
-3,69 m
Other non operating income
-1,15 m
-1,15 m
-
-
EBT including unusual items
-2,38 m
-2,38 m
-3,28 m
-3,28 m
EBT excluding unusual items
-2,24 m
-2,24 m
-3,28 m
-3,28 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-33,28 k
-33,28 k
-54,24 k
-54,24 k
Net income
-2,38 m
-2,38 m
-3,28 m
-3,28 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
563,00
563,00
9,46 k
9,46 k
Interest expense
-54,83 k
-54,83 k
-47,62 k
-47,62 k
Net interest expenses
-54,27 k
-54,27 k
-38,17 k
-38,17 k
Depreciation and amortization charges
137,48 k
137,48 k
123,09 k
123,09 k
EBITDA
-2,13 m
-2,13 m
-3,66 m
-3,66 m
Gain or loss from assets sale
2,30 k
2,30 k
-
-
AI content may include mistakes. Learn more
Google-programme